Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Scientists Unravel the Drama of a Decade of Cancer Research

03.08.2004


Reviewing the last 10 years of cancer research much as they might the production of a play complete with cast members, opening acts and an ever-twisting plot, two of the most cited names in science say that one of the most promising roles that newly discovered cancer genes may perform is in early detection, which likely will be as important as new treatments.

In an editorial review that is the centerpiece of Nature Medicine’s 10th anniversary August issue, Johns Hopkins Kimmel Cancer Center scientists Bert Vogelstein, M.D., and Kenneth Kinzler, Ph.D., used a lengthy Broadway metaphor to suggest that the conquest of cancer is a drama that has lots more acts to come, some of them destined to refocus large parts of the national research effort.

"The best chance of managing these diseases in the next few decades relies on taking advantage of the genes we now know lie at the heart of the process," says Vogelstein, who is the world’s most influential scientist according to citation rankings by the Institute of Scientific Information. "Cancer already is curable when it’s caught early. New methods of detecting cancers, although less dramatic and not as popular, offer very promising approaches for limiting cancer deaths in the future."



In the past, the Hopkins scientists argue that the lack of better "scripts" including key gene characters hindered drug development and early diagnostic efforts. With a refined cast of characters, more researchers may steer their efforts to better diagnostic and therapeutic strategies, which may have a greater impact on cancer death rates.

In their review, Vogelstein and Kinzler describe the progress in understanding cancer and the roles of nearly 100 genes that have been definitively linked to cancer. The opening act introduces three kinds of genes that regulate cancer growth pathways. Oncogenes, when altered, get stuck in active duty, much as a stuck accelerator in a car. In opposite roles, tumor suppressor genes act as malfunctioning brakes. Finally, faulty stability genes act like bad auto mechanics, failing to repair mistakes made in the DNA code during replication or exposure to mutating agents. Genes that control blood supply to a tumor are cast in important supporting roles.

The central plot involves the cell growth pathways that these genes control--discoveries that demonstrate how each gene affects a cascade of protein production that is necessary for cancer development. Remarkably, the majority of these genes, which vary considerably in different cancers, converge on a relatively small number of similar pathways that direct cancer growth, providing a common story line.

"Researchers know many of the genes involved in cancer development and are learning how to put the entire cast together, and we are beginning to understand the best ways to apply gene discoveries to help patients," says Kinzler. "The last decade of gene discovery now sets the stage for this sequel which will include new methods for early detection as well as targeted therapeutics."

In addition to developing more sophisticated tools for early detection of tumors, Vogelstein and Kinzler say other areas of future research should include better models for testing targeted therapies and investigating the functions of novel genes auditioning for leading roles in the cancer process.

Vogelstein and Kinzler have been studying the genetics of cancer for more than 20 years and have made pivotal discoveries of genes and pathways that lead to cancer, including those involving p53, APC, mismatch repair and Gli. Vogelstein is the Clayton Professor of Oncology at the Johns Hopkins Kimmel Cancer Center and Investigator, Howard Hughes Medical Institute. Kinzler is Professor of Oncology and co-directs the Molecular Genetics Laboratory with Vogelstein at the Kimmel Cancer Center. Vogelstein, B. and Kinzler, K. W., Cancer Genes and the Pathways They Control, Nat Med 10(8), August 2004.

| newswise
Further information:
http://www.hopkinskimmelcancercenter.org

More articles from Health and Medicine:

nachricht Shipment tracking for "fat parcels" in the body
14.10.2019 | Rheinische Friedrich-Wilhelms-Universität Bonn

nachricht Antibody-based eye drops show promise for treating dry eye disease
14.10.2019 | University of Illinois at Chicago

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Novel Material for Shipbuilding

A new research project at the TH Mittelhessen focusses on the development of a novel light weight design concept for leisure boats and yachts. Professor Stephan Marzi from the THM Institute of Mechanics and Materials collaborates with Krake Catamarane, which is a shipyard located in Apolda, Thuringia.

The project is set up in an international cooperation with Professor Anders Biel from Karlstad University in Sweden and the Swedish company Lamera from...

Im Focus: Controlling superconducting regions within an exotic metal

Superconductivity has fascinated scientists for many years since it offers the potential to revolutionize current technologies. Materials only become superconductors - meaning that electrons can travel in them with no resistance - at very low temperatures. These days, this unique zero resistance superconductivity is commonly found in a number of technologies, such as magnetic resonance imaging (MRI).

Future technologies, however, will harness the total synchrony of electronic behavior in superconductors - a property called the phase. There is currently a...

Im Focus: How Do the Strongest Magnets in the Universe Form?

How do some neutron stars become the strongest magnets in the Universe? A German-British team of astrophysicists has found a possible answer to the question of how these so-called magnetars form. Researchers from Heidelberg, Garching, and Oxford used large computer simulations to demonstrate how the merger of two stars creates strong magnetic fields. If such stars explode in supernovae, magnetars could result.

How Do the Strongest Magnets in the Universe Form?

Im Focus: Liquifying a rocky exoplanet

A hot, molten Earth would be around 5% larger than its solid counterpart. This is the result of a study led by researchers at the University of Bern. The difference between molten and solid rocky planets is important for the search of Earth-like worlds beyond our Solar System and the understanding of Earth itself.

Rocky exoplanets that are around Earth-size are comparatively small, which makes them incredibly difficult to detect and characterise using telescopes. What...

Im Focus: Axion particle spotted in solid-state crystal

Scientists at the Max Planck Institute for Chemical Physics of Solids in Dresden, Princeton University, the University of Illinois at Urbana-Champaign, and the University of the Chinese Academy of Sciences have spotted a famously elusive particle: The axion – first predicted 42 years ago as an elementary particle in extensions of the standard model of particle physics.

The team found signatures of axion particles composed of Weyl-type electrons (Weyl fermions) in the correlated Weyl semimetal (TaSe₄)₂I. At room temperature,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

International Symposium on Functional Materials for Electrolysis, Fuel Cells and Metal-Air Batteries

02.10.2019 | Event News

NEXUS 2020: Relationships Between Architecture and Mathematics

02.10.2019 | Event News

Optical Technologies: International Symposium „Future Optics“ in Hannover

19.09.2019 | Event News

 
Latest News

How to control friction in topological insulators

14.10.2019 | Physics and Astronomy

The shelf life of pyrite

14.10.2019 | Earth Sciences

Shipment tracking for "fat parcels" in the body

14.10.2019 | Health and Medicine

VideoLinks
Science & Research
Overview of more VideoLinks >>>